Conmed (CNMD) Income from Continuing Operations (2010 - 2026)
Conmed's (CNMD) quarterly Income from Continuing Operations came in at 23071000.0 in Q2 2026, up 7.7% YoY from 21421000.0 in Q2 2025, and up 66.84% on a QoQ basis from 13828000.0 in Q1 2026.
Conmed (CNMD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Conmed (CNMD) has 17 years of Income from Continuing Operations data on file, last reported at 23071000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 7.7% year-over-year to 23071000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 56497000.0 (down 48.73% YoY) and the FY2025 annual result came in at 47055000.0, down 64.47% from the prior year.
- Income from Continuing Operations climbed to 23071000.0 in Q2 2026, from 13828000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 48984000.0 in Q3 2024 to a low of 168291000.0 in Q2 2022.
- A 5-year average of 11125277.78 and a median of 18224000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 1366.3% — and 2024, when it surged 983.51%.
- Tracing CNMD's Income from Continuing Operations over 5 years: stood at 26584000.0 in 2022, then advanced by 24.4% to 33071000.0 in 2023, then advanced by 2.07% to 33755000.0 in 2024, then slumped by 50.41% to 16739000.0 in 2025, then jumped by 37.83% to 23071000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 23071000.0 (Q2 2026), 13828000.0 (Q1 2026), and 16739000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | 23.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.07 Mn |
| Mar 31, 2026 | 13.83 Mn |
| Dec 31, 2025 | 16.74 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 21.42 Mn |
| Mar 31, 2025 | 6.04 Mn |
| Dec 31, 2024 | 33.76 Mn |
| Sep 30, 2024 | 48.98 Mn |
| Jun 30, 2024 | 29.98 Mn |
| Mar 31, 2024 | 19.71 Mn |
| Dec 31, 2023 | 33.07 Mn |
| Sep 30, 2023 | 15.84 Mn |
| Jun 30, 2023 | 13.73 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 26.58 Mn |
| Sep 30, 2022 | 46.15 Mn |
| Jun 30, 2022 | -168.29 Mn |
| Mar 31, 2022 | 14.98 Mn |
| Dec 31, 2021 | 24.44 Mn |
| Sep 30, 2021 | 14.95 Mn |